# Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

> **NCT00003304** · PHASE2 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 29 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** temozolomide

## Key facts

- **NCT ID:** NCT00003304
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-04
- **Primary completion:** 2000-03
- **Final completion:** —
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2012-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003304, "Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*